Siga Technologies Inc (SIGA) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Siga Technologies Inc  (NASDAQ: SIGA)


Siga Technologies Inc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Siga Technologies Inc's ROA in the second quarter of 2026?
Siga Technologies Inc achieved a return on average assets (ROA) of 5.7 % in its second quarter of 2026, which is below Siga Technologies Inc's average return on assets, which stands at 14.52%.

ROA fell compared to the first quarter of 2026, despite the net income growth of % from the first quarter of 2026.

However, within the Healthcare sector 144 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 682, from total ROA ranking in the first quarter of 2026 at 707.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -22.99 % -11.2 % -6.71 % 25.19 % 27.48 %
Y / Y Net Income Change -22.88 % - - - 1836.2 %
Net Income (TTM) in million 12 20 23 74 82
Return On Assets (TTM) 5.7 % 8.96 % 10 % 31.45 % 36.51 %
SIGA's Total Ranking # 682 # 707 # 143 # 117 # 204
Total Assets (TTM) in million 180 219 219 232 233
Seq. Total Assets Change -18.15 % -0.04 % -5.24 % -0.66 % -5.63 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 55
Sector # 145
Overall # 1060

Return On Assets Statistics
High Average Low
277.21 %
14.52 %
-183.62 %
(Dec 31 2018)   (Sep 30 2016)





Financial Statements
Siga Technologies Inc's Assets $ 180 million SIGA's Balance sheet
Siga Technologies Inc's Income $ 27 million Quarterly SIGA's Income Statement
SIGA's Income by Division See SIGA's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change -6.71 % -7.51 % 30.41 % -9.17 % 43.31 %
Total Assets in million 219 235 254 195 215
Y / Y Net Income Change -60.69 % -13.01 % 100.76 % -51.18 % 23.27 %
Net Income in million 23 59 68 34 69
Annual Return On Assets 10.61 % 25.17 % 26.76 % 17.38 % 32.34 %




Comment on SIGA's ROA in the fiscal year ending 2025
In the fiscal year 2025 Siga Technologies Inc's ROA decreased compared to previous year to 10.61 %, due to deterioration of net income -60.69 % to $23.28 million, from $59.21 million a year ago, as SIGA's assets were $219.47 million.


More Return On Assets Ratios
SIGA's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SIGA's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SIGA's Competitors
Subscribers only: Roa for Siga Technologies Inc's Suppliers
Subscribers only: Return On Assets for SIGA's Customers

You may also want to know
SIGA's Roi SIGA's Inventory Turnover Ratio SIGA's Growth Rates SIGA's Dividend Comparisons
SIGA's Profitability Ratios SIGA's Asset Turnover Ratio SIGA's Dividend Growth
SIGA's Roe SIGA's Valuation Ratios SIGA's Financial Strength Ratios SIGA's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Intuitive Surgical Inc   15.63 %
Healthcare Services Group Inc   15.21 %
Inspire Medical Systems inc   15.21 %
Dexcom Inc   14.87 %
Neurocrine Biosciences Inc   14.73 %
Entera Bio Ltd   14.60 %
Standard Biotools Inc   14.31 %
Arcutis Biotherapeutics Inc   14.23 %
Harmony Biosciences Holdings inc   14.15 %
Biolife Solutions Inc   14.09 %
Aveanna Healthcare Holdings Inc   13.82 %
West Pharmaceutical Services Inc   13.64 %
Medinotec Inc   13.38 %
Puma Biotechnology Inc   13.28 %
Sbc Medical Group Holdings Incorporated  13.26 %
Alpha Pro Tech Ltd   13.17 %
Illumina Inc   12.68 %
Spero Therapeutics Inc   12.57 %
Transmedics Group Inc   12.50 %
Eton Pharmaceuticals Inc   12.37 %
Nephros Inc   12.30 %
Msa Safety Inc  12.23 %
Strata Critical Medical Inc   12.18 %
Insulet Corporation  12.13 %
Lantheus Holdings Inc   11.89 %
Ligand Pharmaceuticals Incorporated  11.68 %
Theravance Biopharma inc   11.68 %
Carlisle Companies Incorporated  11.62 %
Encompass Health Corporation  11.60 %
Protagonist Therapeutics inc   11.02 %


Date modified: 2026-09-08T22:13:13+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.